K2 Infragen Reports Zero Deviation in IPO Proceeds Utilization for September 2026
K2 Infragen Ltd · Others (Uncategorized) · 14 Nov 2026, 11:03 pm
K2 Infragen Reports Zero Deviation in IPO Proceeds Utilization for September 2026 K2 Infragen Limited reported no deviation in the utilization of its IPO proceeds for the half year ended 30th Sep'26, as reviewed by the Audit Committee on 14th Nov'26. Out of total raised proceeds of ₹4,054.09 lakhs, the company has deployed ₹3,728.12 lakhs across working capital (₹1,600.00 lakhs), capital expenditure (₹505.03 lakhs), general corporate purposes (₹923.09 lakhs), and issue expenses (₹700.00 lakhs). The remaining unutilized amount of ₹325.97 lakhs allocated for capex is currently placed in fixed deposits under lien against bank borrowings pending final deployment.
Original exchange filing (PDF)
More announcements from K2 Infragen Ltd
- K2 Infragen Limited has informed the Exchange about Link of Recording · 17 Nov 2026
- K2 Infragen Limited has informed the Exchange about Investor Presentation · 16 Nov 2026
- K2 Infragen Limited has informed the Exchange regarding Appointment of M/s ASA & Associates LLP as Internal Auditors of the company for FY 26-27 · 14 Nov 2026
- K2 Infragen Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the period ended September 30, 2026. · 14 Nov 2026
- K2 INFRAGEN LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the unaudited standalone and consolidated financial results for the half year ended September 30, 2026 and other business matters · 14 Nov 2026
- K2 Infragen Limited has informed the Exchange about Intimation regarding Earnings Conference Call · 07 Nov 2026
- K2 Infragen Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the for the quarter ended September 30, 2026 (Q2 FY 2026-27) · 07 Oct 2026
